OTCMKTS:RSLSD ReShape Lifesciences (RSLSD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About ReShape Lifesciences Stock (OTCMKTS:RSLSD) Get ReShape Lifesciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume6,500 shsAverage Volume1,362 shsMarket Capitalization$1.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview ReShape Lifesciences Inc. is a medical device company focused on the development and commercialization of minimally invasive, endoscopically delivered therapies for obesity and metabolic diseases. The company’s technology platform is designed to address the growing global need for nonsurgical weight-loss solutions by combining novel device engineering with established clinical protocols. The company’s lead product, the ReShape Duo Intragastric Balloon System, consists of two connected balloons that are endoscopically placed in the stomach to reduce stomach volume and promote early satiety. The ReShape Duo system has been granted CE mark approval in Europe and is supported by clinical data demonstrating significant weight-loss outcomes when used in conjunction with dietary and behavioral counseling. ReShape Lifesciences is also pursuing regulatory clearance in the United States and exploring next-generation iterations of its balloon technology. Originally incorporated as ReShape Medical in 2010, the company reorganized under Chapter 11 in 2019 and emerged under its current name to streamline operations and refocus its product pipeline. ReShape devices are commercially available in select European and Middle Eastern markets, and the company conducts ongoing clinical trials in North America to support U.S. regulatory submissions. ReShape Lifesciences trades on the OTC Pink under the symbol RSLSD and maintains a broad patent portfolio covering its intragastric balloon technologies.AI Generated. May Contain Errors. Read More Receive RSLSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ReShape Lifesciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RSLSD Stock News HeadlinesReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive License Agreement With Biorad Medisys for Obalon Gastric Balloon SystemSeptember 21, 2023 | finanznachrichten.deReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon SystemSeptember 21, 2023 | finance.yahoo.com“I called Tesla in 2019. Here's what I'm buying now.”Luke Lango called Tesla's rise back in 2019, when most investors thought the company was headed for bankruptcy. Investors who followed his call saw returns of 22X. Now Lango is tracking Elon Musk's next major venture, one he believes could be bigger than Tesla and SpaceX combined. Lango is sharing the name and ticker with readers at no cost.August 12 at 1:00 AM | InvestorPlace (Ad)ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0June 26, 2023 | finance.yahoo.comReShape Lifesciences® to Participate in Investor and Industry Conferences in JuneJune 14, 2023 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2023 Earnings Call TranscriptMay 17, 2023 | insidermonkey.comReShape Lifesciences Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-MarketApril 20, 2023 | finance.yahoo.comReShape Lifesciences(R) Receives Notice of Allowance for U.S. Patent Related to its Obalon(R) Balloon SystemApril 12, 2023 | marketwatch.comSee More Headlines RSLSD Stock Analysis - Frequently Asked Questions How do I buy shares of ReShape Lifesciences? Shares of RSLSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolOTCMKTS:RSLSD CIKN/A Webwww.reshapelifesciences.com Phone949-429-6680FaxN/AEmployees50Year Founded2002Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$81.15 million Net Margins-668.58% Pretax MarginN/A Return on Equity-163.22% Return on Assets-52.10% Debt Debt-to-Equity Ratio0.05 Current Ratio1.17 Quick Ratio1.07 Sales & Book Value Annual Sales$610 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.08 Book Value$341.84 per share Price / BookN/AMiscellaneous Outstanding Shares354,000Free FloatN/AMarket Cap$1.90 million OptionableNot Optionable Beta2.03 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:RSLSD) was last updated on 8/12/2026 by MarketBeat.com Staff. From Our PartnersI’ll probably get hate mail for this (but it’s worth it)A Texas tech company is sitting on a $51 billion backlog, building the infrastructure behind Grok, Nvidia's AI...InvestorPlace | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredIran War: What Happened at 1:11 P.M. Outside D.C.?A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored$8B is moving in... are you?Venture capital investment in US crypto companies hit $7.9 billion last year, up 44 percent from the year befo...Awesomely | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe government values gold at $42. It's really $4,800.The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
